Review of pivotal trial results for a triple-hormone obesity therapy and its reported effects on weight, glycemia, and related comorbidities.
Key Takeaways
- These findings demonstrate what may be possible when we treat obesity and impact overall health
- Retatrutide delivered reductions of up to 41.0% in triglycerides
- Retatrutide demonstrated reductions of up to 39.6% in triglycerides